Substituted-pent-4-ynoic acids

A compound of Formula (I) ##STR9## wherein:

• R.sub.1 is --(CR.sub.4 R.sub.5).sub.n C(O)O(CR.sub.4 R.sub.5).sub.m R.sub.6, --(CR.sub.4 R.sub.5).sub.n C(O)NR.sub.4 (CR.sub.4 R.sub.5).sub.m R.sub.6, --(CR.sub.4 R.sub.5).sub.n O(CR.sub.4 R.sub.5).sub.m R.sub.6, or --(CR.sub.4 R.sub.5).sub.r R.sub.6 wherein the alkyl moieties unsubstituted or substituted with one or more halogens;
• m is 0to 2;
• n is 1 to 4;
• r is 0to 6;
• R.sub.4 and R.sub.5 are independently selected hydrogen or C.sub.1-2 alkyl;
• R.sub.6 is hydrogen, methyl, hydroxyl, aryl, halo substituted aryl, aryloxyC.sub.1-3 alkyl, halo substituted aryloxyC.sub.1-3 alkyl, indanyl, indenyl, C.sub.7-11 polycycloalkyl, tetrahydrofuranyl, furanyl, tetrahydropyranyl, pyranyl, tetrahydrothienyl, thienyl, tetrahydrothiopyranyl, thiopyranyl, C.sub.3-6 cycloalkyl, or a C.sub.4-6 cycloalkyl containin one or two unsaturated bonds, wherein the cycloalkyl or heterocyclic moiety is unsubstituted or substituted by 1 to 3 methyl groups, one ethyl group, or an hydroxyl group;
• provided that:
• (a) when R.sub.6 is hydroxyl, then m is 2;
• or
• (b) when R.sub.6 is hydroxyl, then r is 2 to 6;
• or
• (c) when R.sub.6 is 2-tetrahydropyranyl, 2-tetrahydrothiopyranyl, 2-tetrahydrofuranyl, or 2-tetrahydrothienyl, then m is 1 or 2;
• or
• (d) when R.sub.6 is 2-tetrahydropyranyl, 2-tetrahydrothiopyranyl, 2-tetrahydrofuranyl,or 2-tetrahydrothienyl, then r is 1 to 6;
• (e) when n is 1 and m is 0, then R.sub.6 is other than H in --(CR.sub.4 R.sub.5).sub.n O(CR.sub.4 R.sub.5).sub.m R.sub.6;
• X is YR.sub.2, fluorine, NR.sub.4 R.sub.5, or formyl amine;
• Y is O or S(O).sub.m' ;
• m' is 0, 1,or2;
• X.sub.2 is O or NR.sub.8;
• X.sub.3 is hydrogen or X;
• R.sub.2 is independently selected from --CH.sub.3 or --CH.sub.2 CH.sub.3 optionally substituted by 1 or more halogens;
• W is alkynyl of 2 carbon atoms;
• R.sub.3 is H or R.sub.7;
• Z is C(O)R.sub.13, (CH.sub.2).sub.0-1 C(O)OR.sub.13, (CH.sub.2).sub.0-1 C(O)NR.sub.10 R.sub.13, (CH.sub.2).sub.0-1 C(R.sub.8 R.sub.8)OR.sub.8, --NHC(O)R.sub.7, (CH.sub.2).sub.0-1 NR.sub.10 R.sub.13, NH[C(O)C(O)OR.sub.8 ], CH.sub.2 NH[C(O)CNR.sub.10 R.sub.13 ], CH.sub.2 S(O)qR.sub.7, CH[S(O)qR.sub.7 ].sub.2, dithiolane, (tetrazol-5-yl), thiazol-2-yl, [1,2,4]thiadiazol-5-yl, [1,3,4]oxadiazol-2-yl, imidazol-2-yl, oxazol-2-yl, or (3- or 5-oxadiazolyl[1,2,4];
• wherein each of the heterocylic ring systems are unsubstituted or substituted one or more times by R.sub.9 ;
• and wherein q is 0, 1 or 2;
• R.sub.7 is --(CR.sub.4 R.sub.5).sub.q R.sub.11 or C.sub.1-6 alkyl wherein the R.sub.11 or C.sub.1-6 alkyl group is unsubstituted or substituted one or more times by methyl or ethyl unsubstituted or substituted by 1-3 fluorines, --NR.sub.8 R.sub.10, --CO.sub.2 R.sub.8, --O(CH.sub.2).sub.q R.sub.8, --NR.sub.8 C(O)R.sub.8 or R.sub.12 ;
• q is 0, 1,or 2;
• R.sub.8 is independently selected from hydrogen or R.sub.9 ;
• R is C.sub.1-4 alkyl optionally substituted by one to three fluorines;
• R.sub.10 is OR.sub.8 or R.sub.8 ;
• R.sub.11 is pyrimidyl, (1- or 2-imidazolyl), or phenyl;
• R.sub.12 is oxadiazolyl, or thiadiazolyl, and each of these heterocyclic rings is connected throuh a carbon atom and each may be unsubstituted or substituted by one or two C.sub.1-2 all groups unsubstituted or substituted by one to three fluorines;
• R.sub.13 is hydrogen or R.sub.7 ;
• or when R.sub.10 and R.sub.13 are as NR1OR13 they may toether with the nitroen form a 5 to 7 membered ring comprised of carbon or carbon and one or more additional heteroatoms selected from O, N, or S, wherein the additional nitroen heteroatom may be unsubstituted or substituted by one or two C.sub.1-2 alkyl groups unsubstituted or substituted by one to three fluorines;
• R.sub.14 is hydrogen, C(O)R.sub.13, C(O)OR.sub.13, C(O)NR.sub.10 R.sub.13, OR.sub.8, or S(O).sub.q R.sub.7 where q is 0, 1 or2;
• or the pharmaceutically acceptable salts thereof.